POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY
    5.
    发明公开
    POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY 审中-公开
    具有HIV整合酶抑制活性的多环氨基甲酰基吡啶酮衍生物

    公开(公告)号:EP3284519A1

    公开(公告)日:2018-02-21

    申请号:EP17195276.5

    申请日:2006-04-28

    摘要: The present invention is to provide a novel compound (I-1) shown below, having the anti-virus activity, particularly the HIV integrase inhibitory activity, and a drug containing the same, particularly an anti-HIV drug, as well as a process and an intermediate thereof.

    wherein
    A ring is substituted ring of (a), (b) or (c)

    wherein Z is O or NR 19 ,
    R 19 is hydrogen, C 1-10 alkyl, C 2-8 alkenyl, C 1-10 alkylcarbonyl or C 1-10 alkylsulfonyl, and the other substituents on the A ring form a ring;
    R 14 and R X are hydrogen;
    a broken line represents the presence or absence of a bond, provided that when the broken line represents the presence of a bond, R X is not present;
    R 1 is hydrogen or C 1-10 alkyl;
    X is C 1-6 alkylene;
    R 2 is phenyl or phenyl substituted with at least halogen;
    R 3 is hydrogen, halogen, hydroxy, C 1-10 alkyl, C 2-8 alkenyl, C 1-10 alkoxy, C 2-8 alkenyloxy or amino;
    or a pharmaceutically acceptable salt, or solvate thereof.

    摘要翻译: 本发明提供具有抗病毒活性,特别是HIV整合酶抑制活性的以下所示的新型化合物(I-1),含有其的药物,特别是抗HIV药物,以及方法 及其中间物。 其中A环为(a),(b)或(c)的取代环,其中Z为O或NR19,R19为氢,C1-10烷基,C2-8链烯基,C1-10烷基羰基或C1-10烷基磺酰基, A环形成一个环; R14和RX是氢; 虚线表示存在或不存在键,条件是当虚线表示存在键时,RX不存在; R1是氢或C1-10烷基; X是C 1-6亚烷基; R2是苯基或至少被卤素取代的苯基; R3是氢,卤素,羟基,C1-10烷基,C2-8链烯基,C1-10烷氧基,C2-8链烯氧基或氨基; 或其药学上可接受的盐或溶剂化物。